Bimonthly internal assessment

 1) A 55 year old man with Recurrent Focal Seizures

Detailed patient case report here: http://ushaindurthi.blogspot.com/2020/11/55-year-old-male-with-complaints-of.html


1. What is the problem representation of this patient and what could be the anatomical site of lesion ?
A.55 Y M patient who is a mestri worker came with c/o inability to move his right upper limb and episodes of seizures.He is a chronic alcoholic and beedi smoker since 35 years.
Lesions may be seen in left fronto parietal temporal and occipital lobes.mostly temporal region.


2. Why are subcortical internal capsular infarcts more common that cortical infarcts?
A.
small subcortical infarcts (RSSIs) mostly result from the occlusion of a single, small, brain artery due to intrinsic cerebral small-vessel disease (CSVD). Some RSSIs may be attributable to other causes such as cardiac embolism or large-artery disease, and their association with coexisting CSVD and vascular risk factors may vary with morphological magnetic resonance imaging (MRI) features.

https://pubmed.ncbi.nlm.nih.gov/26043763/

3. What is the pathogenesis involved in cerebral infarct related seizures?
A.

4. What is your take on the ecg? And do you agree with the treating team on starting the patient on Enoxaparin?

A. Ventricular ectopics seen

Left axis deviation +
ST depressions noted in precordial leads V1 to V6

NSTEMI

Yes I agree With treating team on starting with enoxaparin. 
[ ] https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.109.555003#:~:text=Background%20and%20Purpose%E2%80%94%20The%20Prevention,but%20statistically%20significant%20increase%20in

5. Which AED would you prefer?
If so why?

Please provide studies on  efficacies of each of the treatment given to this patient.

A. I prefer Carbamazepine and levetiracetam.
Antiepileptics:
The latest ILAE report recommends that for efficacy, as initial monotherapy in adults with focal seizures, carbamazepine (CBZ), levetiracetam (LEV), phenytoin (PHT) and zonisamide have level A evidence. For elderly patients, lamotrigine (LTG) and gabapentin (GBP) have level A evidence.71 In the Standard and New Antiepileptic Drugs (SANAD) trial, the efficacy and tolerance were compared among GBP, LTG, oxcarbazepine (OCBZ) and topiramate in patients with partial epilepsy. GBP was found to be less effective and LTG was better tolerated than the other drugs.72 In the Keppra vs Older Monotherapy in Epilepsy Trial (KOMET trial, LEV, valproic acid (VPA) and CBZ were compared as initial monotherapy in elderly patients (>60 years old). It was found that LEV had better tolerance and less severe treatment withdrawal effects than other AEDs, but no difference was detected in drug efficacy.

Antiepileptics https://pubmed.ncbi.nlm.nih.gov/28661008/

Atorvastatin https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036014/

Aspirin https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206448/

Enoxaparin https://www.sciencedirect.com/science/article/pii/S0735109702029017

Question 2) 55 year old man with Recurrent hypoglycemia

Patient details in the intern logged online case report here: http://manojkumar1008.blogspot.com/2020/12/shortness-of-breath-with-high-sugars.html

Questions:

1. What is the problem representation for this patient? 
A.55Y M patient with DM II and HTN since 10 years and on medications came with c/o sudden onset dizziness,profuse sweating,secondary to OHA induced hypoglycemia, exertional dyspnea and cough with no sputum. since 3 days

2. What is the cause for his recurrent hypoglycemia? And how would you evaluate? 
A.https://www.researchgate.net/publication/23669098_Drug-Induced_Hypoglycemia_A_Systematic_Review
May be due to drug over dose and alcohol intake.
Alcohol causes increased sugar levels, in the blood leading to increased insulin release leading to hypoglycaemia.

3. What is the cause for his Dyspnea? What is the reason for his albumin loss?

A. DYSPNEA:

Obesity increases the work of breathing because of the reductions in both chest wall compliance and respiratory muscle strength.

Excess metabolically active adipose tissue plus increased workload on supportive respiratory muscle leads to increased CO2 production (hypercapnia) and increased O2 consumption (hypoxia).

Pulmonary function abnormalities resulting from obesity

HYPOALBUMINEMIA:

Spot protein creatinine ratio > 1 --- albuminuria secondary to ? diabetic nephropathy

4. What is the pathogenesis involved in hypoglycemia ?

A. 

5. Do you agree with the treating team on starting the patient on antibiotics? And why? Mention the efficacies for the treatment given.

A. Yes i agree with the treating team starting antibiotics as his renal parameters are deranged and he may be having AKI (?renal)

CUE / urine cultures / USG abdomen are not available to support it as renal cause of AKI

Spot urine sodium is high may be secondary to ATN

Question 3)

A. 41 year old man with Polyarthralgia

Case details here: https://mahathireddybandari.blogspot.com/2020/11/41m-with-chest-pain-and-joint-pains.html?m=1

1. How would you evaluate further this patient with Polyarthralgia?

A.

2. What is the pathogenesis involved in RA?
A.

3. What are the treatment regimens for a patient with RA and their efficacies?

A.

The following abbreviations and nomenclature for disease-modifying antirheumatic drugs (DMARDs) were used in this document:

csDMARD: conventional synthetic disease-modifying antirheumatic drugs - methotrexate, leflunomide, sulfasalazine, and antimalarial drugs (hydroxychloroquine and chloroquine).

tsDMARD: synthetic target-specific disease-modifying antirheumatic drug - tofacitinib.

bDMARD: biological disease-modifying antirheumatic drugs - tumor necrosis factor inhibitors/TNFi (adalimumab, certolizumab, etanercept, golimumab, infliximab), T-lymphocyte co-stimulation modulator (abatacept), anti-CD20 (rituximab), and IL-6 receptor blocker (tocilizumab).

boDMARD: original biological disease-modifying antirheumatic drugs.

bsDMARD: biosimilar biological disease-modifying antirheumatic drugs.

https://www.hopkinsarthritis.org/arthritis-info/rheumatoid-arthritis/ra-treatment/

Question 3(B)
75 year old woman with post operative hepatitis following blood transfusion
Case details here: https://bandaru17jyothsna.blogspot.com/2020/11/this-is-online-e-log-book-to-discuss.html

1.What are your differentials for this patient and how would you evaluate?

A.Post transfusion delayed hemolytic reaction
Evaluation:
ABO and Rh compatability
coombs testing 
antibody panel testing

https://www.learnhaem.com/courses/frcpath-transfusion/lessons/antibody-screening-and-identification/topic/antigrams/

-Transfusion related acute hepatic injury (TRAHI)
-Post transfusion hepatitis
-Ischemic hepatitis

Evaluation:

2. What would be your treatment approach? Do you agree with the treatment provided by the treating team and why? What are their efficacies?

Symptomatic management:
I agree with the treatment provided by the treating team 

Lasix & Nebulization : For wheezing and crepts
Lactulose :https://pubmed.ncbi.nlm.nih.gov/27089005/
Zofer : For vomitings
Pantop : To prevent gastritis

 Question 4) 60 year woman with Uncontrolled sugars
http://manojkumar1008.blogspot.com/2020/12/60-yr-old-female-with-uncontrolled.html

1. What is the problem representation of this patient?

A 60 year old female with T2DM & HTN since 2 years c/o pricking type of chest pain since 4 days and uncontrolled sugars secondary to ? right upper lobe pneumonic consolidation with sepsis 

2. What are the factors contributing to her uncontrolled blood sugars?

3. What are the chest xray findings?

Plain radiograph of chest , frontal view

Trachea shifted towards right
Hyperdense area noted in the right upper lobe 

(consolidation)

Peripheral pulmonary vasculature is normal

Heart is central in position

Cardiac size normal

The domes of diaphragm are normal in position and smooth outline

Visualized bones and soft tissue appear normal

4. What do you think is the cause for her hypoalbuminaemia? How would you approach it?

• Inflammation (acute phase reactant)
• Malnutrition
• Albuminuria (protein losing nephropathy)

Approach to hypoalbuminemia:

5. Comment on the treatment given along with each of their efficacies with supportive evidence.

• Piptaz & clarithromycin : for his right upper lobe pneumonic consolidation and sepsis
• Egg white & protien powder : for hypoalbuminemia
• Lactulose : for constipation
• Actrapid / Mixtard : for hyperglycemia
• Tramadol : for pain management
• Pantop : to prevent gastritis
• Zofer : to prevent vomitings

Question 5) 56 year old man with Decompensated liver disease

Case report here:  https://appalaaishwaryareddy.blogspot.com/2020/11/56year-old-male-with-decompensated.html

1. What is the anatomical and pathological localization of the problem?
A.Liver : Chronic liver disease (cirrhosis) secondary to HBV

Kidney : AKI on CKD (Hepatorenal syndrome) , Hyperkalemia

GI : GAVE , portal hypertensive gastropathy

Lung : pneumonia , pleural effusion

2. How do you approach and evaluate this patient with Hepatitis B?
A. 

3. What is the pathogenesis of the illness due to Hepatitis B?
A.Hepatitis B?

4. Is it necessary to have a separate haemodialysis set up for hepatits B patients and why?
A.

Yes , separate machines must be used for patients known to be infected with HBV (or at high risk of new HBV infection). A machine that has been used for patients infected with HBV can be used again for non-infected patients only after it has been decontaminated using a regime deemed effective against HBV because of increased risk of transmission due to contamination.

https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-019-1529-1

5. What are the efficacies of each treatment given to this patient? Describe the efficacies with supportive RCT evidence. 
A.

• Lactulose : for prevention and treatment of hepatic encephalopathy.  https://pubmed.ncbi.nlm.nih.gov/27089005/

• Tenofovir : for HBV

• Octreotide : for upper GI bleed.  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1750992/#:~:text=In%20a%20meta-analysis%2C%20somatostatin,(mostly%20caused%20by%20gastritis).

• Lasix : for fluid overload (AKI on CKD)  https://www.ncbi.nlm.nih.gov/books/NBK499921/#:~:text=The%20Food%20and%20Drug%20Administration,failure%20including%20the%20nephrotic%20syndrome.

• Vitamin -k : for ? Deranged coagulation profile (PT , INR & APTT reports not available)

• Pantop : for gastritis

• Zofer : to prevent vomitings

• Monocef (ceftriaxone) : for AKI (? renal)

Question 6) 58 year old man with Dementia
Case report details: http://jabeenahmed300.blogspot.com/2020/12/this-is-online-e-log-book-to-discuss.html

1. What is the problem representation of this patient?

A 58 year old weaver occasional alcoholic c/o slurring of speech , deviation of mouth to right side associated with drooling of saliva , food particles and water predominantly from left angle of mouth and smacking of lips since 6 months.

Urinary urge incontinence since 6 months.

Forgetfulness since 3 months.

He has delayed response to commands.

Dysphagia to both solids and liquids since 10 days.

K/c/o CVA 3 years back and now he was diagnosed as neuro degenerative disease - Alzheimer's (? Vascular - post stroke sequale)

2. How would you evaluate further this  patient with Dementia?

3. Do you think his dementia could be explained by chronic infarcts?

Yes 

ABBREVIATIONS

AD : Alzheimer’s disease

CH : cerebral haemorrhage

CVD : cerebrovascular disease

MI : myocardial infarction

MID : multi-infarct dementia

LVD : large vessel disease

SIVD : subcortical ischaemic vascular dementia

SVD : small vessel disease

VCI : vascular cognitive impairment

VaD : vascular dementia

4. What is the likely pathogenesis of this patient's dementia?

Post stroke dementia

5. Are you aware of pharmacological and non pharmacological interventions to treat such a patient and what are their known efficacies based on RCT evidence?

A.  PHARMACOLOGIC:
Cholinesterase inhibitors:
Donepezil
Rivastigmine
Galantamine
NMDA antagonist:
Memantine

NON PHARMACOLOGIC:
Counselling the patient and care givers
Geriatric care
Cognitive / emotion oriented interventions
Sensory stimulation interventions
Behaviour management techniques. 

Efficacy:

https://pubmed.ncbi.nlm.nih.gov/9443470/

Question 7) 22 year old man with seizures
Case report here http://geethagugloth.blogspot.com/2020/12/a-22-year-old-with-seizures.html

1. What is the problem representation of this patient ? What is the anatomic and pathologic localization in view of the clinical and radiological findings? 

A.  22 year old delivery boy chronic alcoholic and tobacco chewer c/o on & off fever since 1 year , involuntary weight loss since 6 months , headache since 2 months , 4 - 5 episodes of involuntary stiffening of both UL & LL with 5 min LOC 1 week before the day of admission.

Brain - multiple ring enhancing lesions in right cerebellum ? Tuberculoma

RVD positive

2. What the your differentials to his ring enhancing lesions?

Bacterial

Pyogenic abscess

Tuberculoma and tuberculous abscess Mycobacterium avium-intracellulare infection Syphilis

Listeriosis

Fungal

Nocardiosis

Actinoimycosis 

Rhodococcosis 

Zygomycosis

Histoplasmosis

Coccidioidomycosis

Aspergillosis

Mucormycosis

Paracoccidioidomycosis

Cryptococcosis

Parasitic

Neurocysticercosis

Toxoplasmosis

Amoebic brain abscess

Echinococcosis

Cerebral sparganosis

Chagas\" disease

Neoplastic

Metastases

Primary brain tumor

Primary CNS lymphoma

Inflammatory and demyelinating

Multiple sclerosis

Acute disseminated encephalomyelitis

Sarcoidosis

Neuro-Behcet.s disease

Whipple\"s disease

Systemic lupus erythematosus

3. What is "immune reconstitution inflammatory syndrome IRIS and how was this patient\"s treatment modified to avoid the possibility of his developing it?

A paradoxical clinical worsening of a known condition or the appearance of a new condition after initiating anti retroviral therapy (ART) therapy in HIV-infected patients resulting from restored immunity to specific infectious or non-infectious antigens is defined as immune reconstitution inflammatory syndrome (IRIS).

As his CD4 count is > 50 /mm3 consider delayed initiation of ART ideally after 8 weeks of starting ATT to reduce the chances of developing IRIS

Question 8) Please mention your individual learning experiences from this month.

A. 1.Post stroke dementia and its management 

     2.CVA and its management 

     3.Status epilepticus and its management. 

     4.Diabetic nephropathy and its diagnosis 

     5 .Nstemi and stemi clinical features 

     6.Hypoglycemia effects on the body and management. 

     7. Transfusion reactions.